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Abstract. 
 
Sphingosine-1-phosphate (SPP) is a bioac-
tive lipid that has recently been identiﬁed as the ligand 
for the EDG family of G protein–coupled cell surface 
receptors. However, the mitogenic and survival effects 
of exogenous SPP may not correlate with binding to 
cell-surface receptors (Van Brocklyn, J.R., M.J. Lee, R. 
 
Menzeleev, A. Olivera, L. Edsall, O. Cuvillier, D.M. Tho-
mas, P.J.P. Coopman, S. Thangada, T. Hla, and S. Spie-
gel. 1998. 
 
J. Cell Biol.
 
 142:229–240). The recent cloning 
of sphingosine kinase, a unique lipid kinase responsible 
for the formation of SPP, has provided a new tool to in-
vestigate the role of intracellular SPP. Expression of 
sphingosine kinase markedly increased SPP levels in 
NIH 3T3 ﬁbroblasts and HEK293 cells, but no detect-
able secretion of SPP into the medium was observed. 
The increased sphingosine kinase activity in NIH 3T3 
ﬁbroblasts was sufﬁcient to promote growth in low-
serum media, expedite the G
 
1
 
/S transition, and increase 
DNA synthesis and the proportion of cells in the 
S phase of the cell cycle with a concomitant increase in 
cell numbers. Transient or stable overexpression of
sphingosine kinase in NIH 3T3 ﬁbroblasts or HEK293 
cells protected against apoptosis induced by serum dep-
rivation or ceramide elevation. 
 
N
 
,
 
N
 
-Dimethylsphin-
gosine, a competitive inhibitor of sphingosine kinase, 
blocked the effects of sphingosine kinase overexpres-
sion on cell proliferation and suppression of apoptosis. 
In contrast, pertussis toxin did not abrogate these bio-
logical responses. In Jurkat T cells, overexpression of 
sphingosine kinase also suppressed serum deprivation- 
and ceramide-induced apoptosis and, to a lesser extent, 
Fas-induced apoptosis, which correlated with inhibition 
of DEVDase activity, as well as inhibition of the execu-
tionary caspase-3. Taken together with ample evidence 
showing that growth and survival factors activate sphin-
gosine kinase, our results indicate that SPP functions as 
a second messenger important for growth and survival 
of cells. Hence, SPP belongs to a novel class of lipid me-
diators that can function inside and outside cells.
Key words: sphingosine kinase • sphingosine-1-phos-
phate • cell growth • apoptosis
 
S
 
PHINGOSINE
 
-1-phosphate (SPP),
 
1
 
 a phosphorylated
derivative of sphingosine, the structural backbone
of all sphingolipids, is a bioactive lipid that regulates
diverse biological processes, such as calcium mobilization,
cell growth, differentiation, survival, motility, and cyto-
skeleton organization (Goetzl and An, 1998; Spiegel, 1999).
Recent interest in SPP has been stimulated by the discov-
ery of a family of cell surface G-protein–coupled receptors
(GPCR), encoded by the endothelial differentiation genes
(EDG), that specifically bind SPP with high affinity and
specificity (An et al., 1997; Goetzl and An, 1998; Lee et al.,
1998; Van Brocklyn et al., 1998, 1999; Kon et al., 1999),
supporting a role for SPP as an extracellular mediator. In-
deed, previously, some of the biological effects of SPP
when added exogenously, such as inhibition of platelet ac-
tivation and motility and cell shape changes (Yamamura
et al., 1997), induction of neurite retraction and soma
rounding (Postma et al., 1996; Sato et al., 1997), and acti-
vation of G
 
i
 
 protein–gated inward rectifying K
 
1
 
 channels
in atrial myocytes (van Koppen et al., 1996), have been at-
tributed to interactions with putative cell surface recep-
tors. SPP receptors, EDG-1, -3, and -5, couple to different
G
 
a
 
s and 
 
bg
 
 dimers to signal through cAMP, phospholi-
pase C, Ras, mitogen-activated protein kinase, Rho, and
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several protein tyrosine kinases (An et al., 1997; Goetzl
and An, 1998; Lee et al., 1998; Okamoto et al., 1998; Van
Brocklyn et al., 1998; Zondag et al., 1998; Gonda et al.,
1999). Furthermore, SPP is stored in high concentrations
in human platelets, from which it is released upon activa-
tion by physiological stimuli (Yatomi et al., 1997a), sug-
gesting that SPP can be considered an autocrine factor in-
volved in endothelial injury, inflammation, thrombosis,
and angiogenesis.
However, this sphingolipid metabolite also has many of
the hallmarks of classical second messengers (reviewed in
Spiegel et al., 1996). The level of SPP is very low in cells
and is rapidly increased by activation of sphingosine ki-
nase induced by diverse physiological stimuli, including
PDGF (Olivera and Spiegel, 1993; Bornfeldt et al., 1995;
Coroneos et al., 1995; Pyne et al., 1996), NGF (Edsall et al.,
1997; Rius et al., 1997), muscarinic acetylcholine agonists
(Meyer zu Heringdorf et al., 1998), tumor necrosis factor
(TNF)-
 
a
 
 (Xia et al., 1998), activation of PKC (Mazurek et al.,
1994; Buehrer et al., 1996), and cross-linking of the immu-
noglobulin receptors Fc
 
e
 
R1 (Choi et al., 1996) and Fc
 
g
 
R1
(Melendez et al., 1998). Similar to other signaling mole-
cules, SPP has a short half-life due to rapid turnover cata-
lyzed by SPP lyase and/or SPP phosphatase (Van Veld-
hoven and Mannaerts, 1991, 1994; Saba et al., 1997;
Mandala et al., 1998; Zhou and Saba, 1998). Moreover,
prevention of SPP formation by competitive inhibitors of
sphingosine kinase blunted the mitogenic response to
PDGF (Olivera and Spiegel, 1993; Rani et al., 1997), the
cytoprotective effects of NGF (Edsall et al., 1997), vitamin
D3 (Kleuser et al., 1998), PKC, and cAMP activators (Cu-
villier et al., 1996; Machwate et al., 1998), as well as cal-
cium mobilization induced by Fc
 
e
 
R1, Fc
 
g
 
R1, and muscar-
inic acetylcholine receptors (Choi et al., 1996; Melendez
et al., 1998; Meyer zu Heringdorf et al., 1998). In addition,
microinjected SPP mobilizes calcium from internal sources
(Meyer zu Heringdorf et al., 1998), is mitogenic for Swiss
3T3 fibroblasts (Van Brocklyn et al., 1998), and inhibits
apoptosis of mouse oocytes induced by the antitumor drug
doxorubicin (Perez et al., 1997). Collectively, these obser-
vations provide new insights into the biological functions
of SPP and emphasize the importance of sphingosine ki-
nase, the enzyme responsible for SPP formation, whether
it functions inter- or intracellularly. Until recently, it had
been difficult to critically evaluate the second messenger
roles of SPP because most of the relevant enzymes in-
volved in its metabolism had not been purified and cloned.
Thus, much of the evidence that led to the elucidation of
its importance has been indirect, relying on exogenous
application and the use of inhibitors, and is further com-
plicated by the existence of cell-surface receptors. We
recently purified sphingosine kinase to apparent homo-
geneity from rat kidney (Olivera et al., 1998) and sub-
sequently cloned and characterized the first mammalian
sphingosine kinases (murine SPHK1a and SPHK1b) (Ko-
hama et al., 1998). In this study, we demonstrate that over-
expression of sphingosine kinase markedly increased in-
tracellular mass levels of SPP, enhanced proliferation by
promoting the G
 
1
 
 to S phase transition, and suppressed
serum deprivation- and ceramide-induced apoptosis. Be-
cause these effects were mediated in the absence of detect-
able secretion of SPP and were pertussis toxin indepen-
 
dent, our results support an additional role for SPP as an
intracellular second messenger important for cell prolifer-
ation and survival.
 
Materials and Methods
 
Materials
 
SPP, dihydroSPP, sphingosine, 
 
N,N
 
-dimethylsphingosine, and C2-cer-
amide were from Biomol Research Laboratory Inc. [
 
g
 
-
 
32
 
P]ATP (3,000 Ci/
mmol) was purchased from Amersham Corp. Alkaline phosphatase (bo-
vine intestinal mucosa, type VII-NT) and pertussis toxin were from Sigma
Chemical Co. Serum, medium, and G418 were obtained from Biofluids,
Inc. Restriction enzymes were from New England Biolabs Inc. Mono-
clonal antibodies against c-myc were from Zymed, and anti–mouse Texas
red dye–conjugated goat antibody was from Jackson ImmunoResearch
Laboratories, Inc. The Anti-Fade kit was from Molecular Probes. The
bromodeoxyuridine incorporation detection kit and anti–mouse FITC-
conjugated IgG were obtained from Boehringer Mannheim Biochemicals.
Bisbenzimide hydrochloride (Hoechst 33258) was from Calbiochem Corp.
Acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-AMC) was
from Bachem. Anti-Fas IgM (clone CH-11) was from Upstate Biotechnol-
ogy Inc.
 
Cell Culture 
 
NIH 3T3 fibroblasts (ATCC CRL-1658) and human embryonic kidney
cells (HEK293, ATCC CRL-1573) were grown in high glucose DMEM
containing 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, and 2 mM 
 
L
 
-glu-
tamine supplemented with 10% calf serum and fetal bovine serum, respec-
tively (Kohama et al., 1998). Jurkat T leukemia cells were cultured in
RPMI 1640 containing 10% fetal bovine serum. Before addition of exoge-
nous stimuli, cells were resuspended at a density of 0.75–1 
 
3
 
 10
 
6
 
 cells/ml in
medium containing 5 
 
m
 
g/ml transferrin and 5 
 
m
 
g/ml insulin in place of se-
rum (Cuvillier et al., 1998).
 
Cloning and Expression of Sphingosine Kinase 
 
SPHK1a (accession number AF068748) was subcloned into a modified
pcDNA3 vector (Invitrogen Corp.) to express proteins with an NH
 
2
 
-
terminal c-myc epitope tag (a gift from Dr. Peter Burbelo, Georgetown
University, Washington, DC) by PCR using a 5
 
9
 
 primer with a BamH1 re-
striction site (5
 
9
 
-GAGGGATCCGAACCAGAATGCCCTCGAGGA-
3
 
9
 
), and as the 3
 
9
 
 primer, the last 21 nucleotides of the SPHK1a sequence
with an EcoRI overhang (5
 
9
 
-GAGGAATTCTTATGGTTCTTCTG-
GAGGTGG-3
 
9
 
). For transient expression, plasmids were transfected into
cells using Lipofectamine Plus (Life Technologies, Inc.) according to the
manufacturer’s instructions at a 5:1 ratio with pCEFL-GFP, which en-
codes green fluorescent protein (GFP; a generous gift of Dr. Silvio Gut-
kind, NIH, Bethesda, MD). Transfection efficiencies were typically 30 and
40% for NIH 3T3 and HEK293 cells, respectively. Jurkat T cells were
transfected by electroporation at a cell density of 10
 
6
 
 cells/ml with 15 
 
m
 
g of
DNA using a Gene Pulser apparatus (Bio-Rad Laboratories) at 400 V and
960 
 
m
 
Fa. Stable transfectants containing pcDNA3 plasmids were selected
in medium containing 1 mM sodium pyruvate and 0.5 g/liter G418 (NIH
3T3 fibroblasts) or 1 g/liter G418 (HEK293 and Jurkat cells). For all ex-
periments, nonclonal pools of stably transfected cells were used to avoid
clonal variability.
 
Measurement of SPP 
 
Cells were incubated in low serum or serum-free media for at least 24 h.
The media was then removed, cells were washed with PBS and scraped in
1 ml 25 mM HCl/methanol, and SPP levels were measured essentially as
described (Edsall and Spiegel, 1999). In brief, lipids from the cells were
then extracted with 5 ml of chloroform/methanol/1 M NaCl (2:1:2, vol/vol)
containing 100 
 
m
 
l 3 M NaOH. SPP is water soluble at alkaline pH, and
partitions into the aqueous phase. SPP in the aqueous phase was dephos-
phorylated with alkaline phosphatase (25–50 U) in buffer containing 1.2 M
glycine buffer pH 9.0 and 75 mM MgCl
 
2
 
. After 1 h at 37
 
8
 
C, 40 
 
m
 
l concen-
tration. HCl was added, and sphingosine was extracted and quantitated by
phosphorylation with sphingosine kinase and [
 
32
 
P]ATP (Olivera and Spie-
gel, 1998). Total phospholipids in cellular lipid extracts were quantified by
a colorimetric reaction with malachite green exactly as previously de-
scribed (Edsall et al., 1997). 
Olivera et al. 
 
Sphingosine Kinase Cell Growth and Survival
 
547
 
Measurement of [
 
32
 
P]SPP Release 
 
HEK293 cells were grown to subconfluency in 100-mm dishes in 10% FBS
media, washed and incubated in serum-free media containing 40 
 
m
 
Ci/ml
[
 
32
 
P]orthophosphate for 24 h to label the phospholipid pools to isotopic
equilibrium. In some experiments, sphingosine (5 
 
m
 
M) was added to the
media 10 min before termination of the 24-h incubation period. The me-
dia was then collected and the cells scraped from the dishes. Cellular and
secreted [
 
32
 
P]SPP were extracted in alkaline conditions as described
above, followed by acidic extraction with chloroform/methanol/concentra-
tion. HCl (100:100:1, vol/vol), to partition [
 
32
 
P]SPP into the organic phase.
[
 
32
 
P]SPP was resolved on TLC with 1-butanol/ethanol/acetic acid/water
(80:20:10:20, vol/vol), visualized and quantified as described (Olivera et al.,
1998).
 
Assay of Sphingosine Kinase Activity 
 
Cells were incubated in low serum or serum-free media for at least 24 h,
and then harvested and lysed by freeze-thawing in buffer containing 20 mM
Tris, pH 7.4, 20% glycerol, 1 mM 
 
b
 
-mercaptoethanol, 1 mM EDTA, 1 mM
sodium orthovanadate, 40 mM 
 
b
 
-glycero-phosphate, 15 mM NaF, 10 
 
m
 
g/ml
leupeptin, aprotinin and soybean trypsin inhibitor, 1
 
 
 
mM PMSF, and 0.5 mM
4-deoxypyridoxine. Cell lysates were fractionated into cytosol and mem-
brane fractions by centrifugation at 100,000 
 
g
 
 for 60 min 4
 
8
 
C. Sphingosine
kinase activity was determined in the presence of 50 
 
m
 
M sphingosine, dis-
solved in 5% Triton X-100 (final concentration 0.25%), and [
 
32
 
P]ATP (10
 
m
 
Ci, 1 mM) containing MgCl
 
2
 
 (10 mM) as previously described (Kohama
et al., 1998), and specific activity was expressed as picomoles of SPP formed
per minute per milligram protein.
 
Immunostaining
 
Cells grown on glass coverslips coated with collagen I were incubated
overnight in DMEM supplemented with 2 
 
m
 
g/ml insulin, 2 
 
m
 
g/ml transfer-
rin, and 20 
 
m
 
g/ml BSA. Cells were washed with PBS and fixed in 3.7% for-
malin and 0.1% Triton X-100 for 20 min. After washing with PBS, cells
were permeabilized for 10 min with 0.5% Triton X-100 in PBS, washed
again, and incubated with anti–myc antibody for 20 min at room tempera-
ture. After washing, cells were incubated with anti–mouse antibody conju-
gated with fluorescein or Texas red for 20 min. After washing three times
with PBS, coverslips were mounted on slides using an Anti-Fade kit and
cells were photographed using an inverted fluorescence microscope
(Eclipse TE200; Nikon Inc.) connected to a digital camera (DKC5000;
Sony Corp.).
 
Incorporation of Bromodeoxyuridine
 
24 h after transfection, NIH 3T3 cells were serum starved in DMEM sup-
plemented with 2 
 
m
 
g/ml insulin, 2 
 
m
 
g/ml transferrin, and 20 
 
m
 
g/ml BSA,
and then stimulated with various agents. After 16 h, cells were incubated
for 3 h with bromodeoxyuridine (BrdU, 10 
 
m
 
M), and then fixed in 4%
paraformaldehyde containing 5% sucrose, pH 7.0, for 20 min at room
temperature. After washing with PBS, cells were incubated in permeabili-
zation buffer (0.5% Triton/PBS, pH 7.4, containing 10 mg/ml BSA) for 20
min at room temperature, and then incubated for 1 h at room temperature
with monoclonal anti–BrdU antibody in the presence of DNAse (1,000 U/ml)
(Van Brocklyn et al., 1998). After washing with PBS, cells were stained
with Texas red–conjugated anti–mouse antibody in 5% BSA/PBS for 1 h,
washed with PBS, and then photographed using an inverted fluorescence
microscope connected to a digital camera. Cells expressing GFP and cells
with positive BrdU staining were counted. At least three different fields
were scored with a minimum of 100 cells scored per field.
 
Measurement of DNA Synthesis
 
Stably transfected NIH 3T3 fibroblasts were plated in 24-well clusters at a
density of 5 
 
3 
 
10
 
3
 
 cells/well in DMEM containing 10% calf serum. After
24 h, cells were washed with DMEM containing 0.5% calf serum and incu-
bated in same media. The media was replaced every 2–3 d. At the indi-
cated times, cultures were pulsed with 1 
 
m
 
Ci of [
 
3
 
H]thymidine for 6 h and
radioactivity incorporated into trichloroacetic acid–insoluble material
measured as previously described (Olivera and Spiegel, 1993). Values are
the means of triplicate determinations and standard deviations were rou-
tinely 
 
,
 
10% of the mean.
 
Cell Cycle Analysis 
 
Stably transfected NIH 3T3 fibroblasts were trypsinized and counted. Ali-
quots containing 2 
 
3 
 
10
 
6
 
 cells were centrifuged, washed twice with PBS,
and resuspended in 40 mM citrate buffer, pH 7.6, containing 250 mM su-
crose and 5% DMSO. After propidium iodide staining of cellular DNA,
cell cycle analysis was performed with a FACStar
 
plus®
 
 flow cytofluorome-
ter (Becton Dickinson & Co.) (Goodemote et al., 1995).
 
Analysis of Cell Growth 
 
Stably transfected NIH 3T3 fibroblasts (1,000 cells) were plated in 24-well
plates in DMEM containing 10% calf serum. After 24 h, cells were washed
twice with DMEM and then grown in DMEM containing 0.5 or 10% calf
serum. At the indicated times, cells were washed with PBS, fixed with
70% ethanol for 10 min, and stained with crystal violet. Incorporated dye
was dissolved in 100 
 
m
 
l of 0.1 M sodium citrate in 50% ethanol, pH 4.2,
and the absorbance was measured at 540 nm (Wang et al., 1999a). In some
experiments, cells were trypsinized and counted in a hemocytometer.
 
Determination of Apoptotic Cells 
 
Apoptosis was assessed by staining cells with 8 
 
m
 
g/ml Hoechst in 30%
glycerol/PBS for 10 min at room temperature as previously described (Cu-
villier et al., 1998). Cells expressing GFP were examined with an inverted
fluorescence microscope. Apoptotic cells were distinguished by con-
densed, fragmented nuclear regions. The percentage of intact and apop-
totic nuclei in cells expressing GFP fluorescence was determined (Van
Brocklyn et al., 1999). A minimum of 500 cells were scored in a double-
blinded manner to minimize subjective interpretations. In some experi-
ments, viable cells were determined by trypan blue exclusion.
 
Fluorogenic DEVD Cleavage Enzyme Assays 
 
Enzyme reactions were performed in 96-well plates with 20 
 
m
 
g of cytosolic
proteins and a final concentration of 20 
 
m
 
M Ac-DEVD-AMC substrate as
previously described (Cuvillier et al., 1998). Fluorescent AMC product
formation was measured over a 30-min period at excitation and emission
wavelengths of 360 and 460 nm using a Cytofluor II fluorometer plate
reader (PerSeptive Biosystems).
 
Western Blotting 
 
Cytosolic fractions (10–25 
 
m
 
g) were boiled in Laemmli sample buffer, sep-
arated on 10 or 15% SDS-PAGE, and blotted to nitrocellulose. The mem-
branes were blocked with nonfat dry milk in 0.1% Tween-20–PBS for 2 h,
and incubated overnight with anti–c-myc monoclonal antibody (1 
 
m
 
g/ml)
or 2 h with rabbit antiserum specific for the p17 subunit of caspase-3
(kindly provided by Dr. Donald Nicholson, Merck), in the same buffer
containing 1% nonfat dry milk. Immunocomplexes were detected by en-
hanced chemiluminescence as described previously (Cuvillier et al., 1998).
 
Results
 
Characterization of Cells Expressing
Sphingosine Kinase
 
Similar to our previous results with transiently transfected
cells (Kohama et al., 1998), sphingosine kinase activity
in cell lysates from NIH 3T3 and HEK293 cells stably
expressing c-myc–tagged SPHK1a was dramatically in-
creased (500-fold; Fig. 1 A). Western blot analysis of cy-
tosolic fractions using anti–c-myc antibody revealed a spe-
cific protein band with an apparent molecular weight
consistent with the predicted size of c-myc–sphingosine ki-
nase that was absent in vector-transfected cells (Fig. 1 A,
insert). SPP levels were also elevated in cells expressing
sphingosine kinase by four- to eightfold (Fig. 1 B), a level
that did not correlate with the large fold increase in sphin-
gosine kinase activity measured in vitro.
 
 
 
One possible ex-
planation for this discrepancy is that availability of cellular 
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sphingosine might limit the production of SPP. In agree-
ment with our previous results (Zhang et al., 1991), when
cells were acutely treated with exogenous sphingosine,
which is readily taken up (Olivera et al., 1994, 1997), levels
of SPP were further increased three- to sixfold, suggesting
that although availability of sphingosine may be important
for regulating SPP levels, it is probably not the only critical
factor influencing levels of SPP in cells overexpressing
sphingosine kinase.
Since activated platelets can release SPP (Yatomi et al.,
1995), and the EDG family of G protein–coupled SPP re-
ceptors have recently been identified (An et al., 1997;
Goetzl and An, 1998; Lee et al., 1998; Okamoto et al.,
1998; Van Brocklyn et al., 1998, 1999; Zondag et al., 1998;
Gonda et al., 1999), it was important to determine whether
sphingosine kinase–transfected cells, which have notable
increases in SPP levels, secrete SPP into the medium. No
significant release of SPP into the extracellular media
could be detected by our mass measurements, even after
addition of sphingosine to both NIH and HEK293 sphin-
gosine kinase–transfected cells. To increase the sensitivity
of detection of secreted SPP, we labeled HEK 293 cells to
isotopic equilibrium with [
 
32
 
P]P
 
i
 
 and analyzed the labeled
SPP in cells as well as in the medium (Fig. 1 C). Despite
the large increases in [
 
32
 
P]SPP detected in cells overex-
pressing sphingosine kinase, there was no detectable la-
beled SPP released into the medium. Similar results were
also found with NIH3T3 fibroblasts. However, in agree-
ment with previous studies (Yatomi et al., 1997a), we
could readily detect secretion by human platelets after
thrombin treatment. Both methods to measure SPP levels
gave identical increases in intracellular SPP in transfected
and sphingosine-treated cells. Based on the sensitivity of
these methods (1–2 pmol SPP/sample), it is estimated that
the concentration of SPP in the extracellular media must
be 
 
,
 
0.4 nM, a concentration well below the 
 
K
 
d
 
 for binding
Figure 1. Sphingosine kinase ex-
pression results in an increase in
intracellular but not extracellu-
lar levels of sphingosine-1-phos-
phate. (A) Cytosolic sphingosine
kinase activity was measured in
cells stably transfected with
c-myc–pcDNA3 (filled bars) or
c-myc–pcDNA3-SPHK1a (open
bars). The sphingosine kinase
activity in vector-transfected
cells was 108 6 12 and 111 6 7
pmol/min per mg for NIH 3T3
and HEK293 cells, respectively.
(Inset) Western blot showing ex-
pression of sphingosine kinase.
(1 and 2) Vector-transfected
HEK293 and NIH 3T3 cells, re-
spectively; (3 and 4) SPHK1a-
transfected HEK293 and NIH
3T3 cells, respectively. (B) SPP
levels in cells stably expressing
sphingosine kinase. Transfected
cells were washed and incubated
for 24 h in serum-free media
(HEK293 cells) or serum-free
media containing fatty acid–free
BSA (20 mg/ml), transferrin (2
mg/ml), and insulin (2 mg/ml)
(NIH 3T3 fibroblasts). SPP was
extracted and measured as de-
scribed in Materials and Meth-
ods. Levels of SPP in vector-
transfected cells were 0.119 6
0.003 and 0.012 6 0.002 pmol/
nmol phospholipid for NIH 3T3
and HEK293 cells, respectively.
(C) Cellular and secreted
[32P]SPP. HEK293 cells labeled
to isotopic equilibrium with
[32]Pi for 24 h. [32P]SPP was then
extracted from the cells and the
media as described in Materials and Methods. Duplicate cultures were treated with 5 mM sphingosine 10 min before extraction of lipids
(lanes 2, 4, 6, and 8). In the autoradiograms of the TLC analyses, the arrow indicates the location of SPP visualized with molybdenum
blue spray. 
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of SPP to its receptors (8–25 nM) (Van Brocklyn et al.,
1998, 1999).
 
Localization of Sphingosine Kinase and Stimulation by 
Growth Factors
 
Both membrane-associated and cytosolic sphingosine ki-
nase activities have been described in mammalian tissues
and cell lines (Stoffel et al., 1973; Buehrer and Bell, 1992;
Olivera and Spiegel, 1993; Ghosh et al., 1994; Olivera et al.,
1994). However, the amino acid sequence of murine
SPHK1a suggests that it should be a cytosolic protein (Ko-
hama et al., 1998). In agreement with our previous study
on transiently transfected cells (Kohama et al., 1998), most
of the sphingosine kinase activity in cells stably expressing
c-myc–tagged sphingosine kinase was cytosolic and the
relative amounts of sphingosine kinase activity in cytoplas-
mic versus membrane fractions were similar in vector- and
sphingosine kinase–transfected cells (Table I), suggesting
that the small c-myc tag does not affect localization of
sphingosine kinase. Immunohistochemistry with antibod-
ies against c-myc revealed that sphingosine kinase has a
diffuse distribution in the cytosol and somewhat denser
expression in perinuclear sites in both NIH 3T3 and HEK
293 cells (Fig. 2).
Previously, we and others have shown that PDGF stimu-
lates sphingosine kinase activity in various cell types (Oli-
vera and Spiegel, 1993; Bornfeldt et al., 1995; Pyne et al.,
1996; Rani et al., 1997). PDGF stimulated cytosolic c-myc–
sphingosine kinase activity in transfected NIH 3T3 fibro-
blasts to a similar extent as its effect on endogenous sphin-
gosine kinase (Table I), indicating that c-myc–sphingosine
kinase activity is regulated by the signaling pathways trig-
gered by growth factors in the same manner as the native
enzyme. Unlike activation of protein kinase C, activation
of sphingosine kinase by PDGF does not induce signifi-
cant translocation to the membrane fraction. Collectively,
these data suggest that cells overexpressing sphingosine
kinase are a useful tool to study intracellular actions of
SPP. Interestingly, endogenous SPP was present in both
the cytoplasm and membrane fractions and overexpres-
sion of sphingosine kinase markedly increased both by
nearly the same extent (Table II). In contrast to most
phospholipids, glycosphingolipids, and other sphingolipid
metabolites, such as ceramide and sphingosine, which are
found mainly in membranes, 20% of the total cellular SPP
is in the cytosol (Table II).
 
Effect of Sphingosine Kinase Overexpression on
Cell Proliferation
 
Studies with sphingosine kinase inhibitors suggested that
the mitogenic effect of SPP might be due to intracellular
actions (Olivera and Spiegel, 1993; Van Brocklyn et al.,
1998). However, others have suggested that the mitogenic
effect is mediated by binding of SPP to the EDG family of
G protein–coupled receptors (Goetzl and An, 1998). In
view of this controversy, it was of interest to examine the
proliferation of cells whose intra- rather than extracellular
levels of SPP are increased after transfection with sphin-
gosine kinase. Transient expression of c-myc–sphingosine-
1-phosphate (SPHK) in NIH 3T3 cells not only increased
intracellular levels of SPP, it also increased the proportion
of cells in the S phase of the cell cycle measured as incor-
poration of BrdU into nascent DNA (Fig. 3 A). The
growth promoting effects of sphingosine kinase were fur-
ther enhanced by suboptimal concentrations of PDGF (1
ng/ml) and serum (0.1%) (Fig. 3 A), which are known to
stimulate sphingosine kinase (Olivera and Spiegel, 1993,
and Table I). However, addition of exogenous SPP in-
creased BrdU incorporation in empty vector-transfected
cells twofold, but had no effect on sphingosine kinase–
transfected cells, suggesting that these cells are already
maximally stimulated by their intracellular SPP. It should
be pointed out that these experiments were carried out in
the presence of 2 
 
m
 
g/ml insulin, which is a known survival
factor for these cells and was used to prevent cell death
caused by serum deprivation.
Since transient expression of sphingosine kinase in-
creased the proportion of cells in the S phase, it was of in-
terest to determine whether there was a corresponding
increase as a result of stable transfection. Nonclonal pools
of stably transfected cells were studied to avoid potential
phenotypic changes due to selection and propagation of
clones derived from single individual cells. Stable expres-
sion of sphingosine kinase had a dramatic effect on
[
 
3
 
H]thymidine incorporation into DNA in cells cultured in
low serum media, while DNA synthesis was low in empty
vector-transfected cells over the course of 8 d in 0.5% se-
rum (Fig. 4 A).
DNA flow cytometry was used to characterize the distri-
 
Table I. PDGF Stimulates Sphingosine Kinase Activity in 
Sphingosine Kinase–transfected Cells
 
Cytosolic sphingosine 
kinase activity
Cytosolic 
sphingosine kinase 
activity 
Treatment Vector SPHK
 
percent of total activity pmol/min/mg
 
None 69 68 68 5,900
PDGF (1 ng/ml) ND ND 86 8,992
PDGF (20 ng/ml) 71 78 124 9,092
 
NIH 3T3 cells transfected with c-myc–pcDNA3 (Vector) or c-myc–pcDNA3-SPHK1a
(SPHK) were incubated in serum-free media containing fatty acid–free BSA (20 µg/
ml), and transferrin (2 µg/ml) overnight, and then stimulated with the indicated
concentrations of PDGF for 10 min. Sphingosine kinase activity in cytosol and
particulate fractions was measured as described in Materials and Methods and standard
deviations were 
 
,
 
10%. 
 
Table II. Distribution of SPP in Membrane and
Cytosol Fractions
 
SPP SPP
Fraction Vector SPHK Vector SPHK
 
pmol/mg protein pmol/nmol phospholipid
 
Cytosol 0.45 
 
6
 
 0.014 2.17 
 
6
 
 0.012 0.015 
 
6
 
 0.003 0.111 
 
6
 
 0.044
Membrane 1.7 
 
6
 
 0.16 9.1 
 
6
 
 0.37 0.009 
 
6
 
 0.003 0.056 
 
6
 
 0.007
SPP in cytosol and particulate fractions of HEK 293 cells transfected with c-myc–
pcDNA3 (Vector) or c-myc–pcDNA3-SPHK1a (SPHK) was measured as described in
Materials and Methods. The same samples were also analyzed for phospholipid
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bution of cells in the cell cycle. FACS® analysis revealed
that after 2 d in 0.5% serum, .95% of the vector-trans-
fected NIH 3T3 fibroblasts were in G0/G1 phase and only a
small fraction were in S and G2/M phases (Table III).
Overexpression of sphingosine kinase reduced the fraction
of cells in G0/G1 and, in agreement with the DNA synthe-
sis data, increased the proportion in the S phase and, to a
lesser extent, in the G2/M phase. Even in the presence of
10% serum, which markedly increased the proportion of
cells in the S phase and G2/M phase, sphingosine kinase
transfection further increased the proportion of cells in the
S phase (Table III). This data suggests that either a greater
proportion of sphingosine kinase–transfected cells are cy-
Figure 3. Expression of sphingosine kinase stimulates BrdU incorporation into nascent DNA. (A) NIH 3T3 fibroblasts were transiently
transfected with empty vector (pCMV-SPORT2, filled bars) or pCMV-SPORT2-SPHK1a (open bars) together with pCEFL-GFP. Cells
were serum-starved for 18 h and incubated in serum-free media supplemented with insulin (2 mg/ml) without (None) or with PDGF
(1 ng/ml), FBS (0.1%), or SPP (10 mM). After 16 h, BrdU was added for an additional 3 h. Double immunofluorescence was used to vi-
sualize transfected cells and BrdU incorporation, and the proportion of cells incorporating BrdU among total transfected cells (express-
ing GFP) was determined. Data are means 6 SD of duplicate cultures from a representative experiment. At least three different fields
were scored with a minimum of 100 cells scored per field. Similar results were obtained in three independent experiments. For compar-
ison, in medium containing 10% FBS, 42.3 6 4.9% of the vector-transfected cells incorporated BrdU. (B) Representative images of
cells treated with a suboptimum concentration of PDGF (1 ng/ml). Vector- and sphingosine kinase–transfected NIH 3T3 cells express-
ing GFP (left) and incorporating BrdU (right) were visualized by double immunofluorescence. Arrows indicate cells that are positive
for both.
Figure 2. Cellular localization of c-myc–sphingosine kinase.
NIH3T3 fibroblasts transiently or stably expressing sphingosine
kinase and HEK293 cells stably expressing sphingosine kinase
were incubated with a monoclonal c-myc antibody (20 mg/ml)
and stained with anti–mouse Texas red–conjugated IgG (1:100
dilution) (left) or anti–mouse FITC-monoclonal IgG (1:10 dilu-
tion) (right). Fluorescence micrographs (603) were taken using
an inverted fluorescent microscope. Vector transfectants (c-myc–
pcDNA3) did not show any significant fluorescence.Olivera et al. Sphingosine Kinase Cell Growth and Survival 551
cling and/or that the duration of the G1 phase is shortened
compared with vector-transfected cells.
Growth curves in low serum of vector and sphingosine
kinase–transfected 3T3 fibroblasts diverged after 2 d and
growth of the sphingosine kinase–transfected cells was
markedly enhanced thereafter, demonstrating that the al-
teration in cell-cycle distribution resulted in increased
growth rate (Fig. 4 B). Moreover, even in the presence of
10% serum, sphingosine kinase expression was still able to
significantly increase proliferation (Fig. 4 C), and to in-
crease the saturation density (not shown).
Analyses of the growth curves during the exponential
growth phase revealed that sphingosine kinase expression
decreased the doubling time in 0.5% calf serum from 34 6
1.4 to 27 6 1.8 h, although no differences were observed in
the doubling times in full serum (vector, 17 6 2.2 h; SPHK,
16 6 1.2 h). Furthermore, computation of the parameters
of the cell cycle during exponential growth revealed that
sphingosine kinase markedly shortened the duration of G1
phase of the cell cycle by 31 6 2% in low serum, suggesting
that sphingosine kinase is important for nontransformed
cells to progress through the G1-S boundary. However, in
cells growing in full serum, although overexpression of
sphingosine kinase increases the proportion of cells in S
phase with a corresponding decrease in G0/G1 (Table III),
there were no significant changes in the duration of either
of these phases of the cell cycle.
To further investigate the possibility that the EDG fam-
Figure 4. Expression of sphingosine kinase stimulates growth of NIH 3T3 fibroblasts cultured in low serum. (A) Cells stably transfected
with c-myc–pcDNA3 (j) or with c-myc–SPHK-pcDNA3 (h) were plated at low density, washed after 24 h, and cultured in 0.5% calf
serum for the indicated days. Media was replaced every 2 d, the cells were pulsed at the indicated times with [3H]thymidine for an addi-
tional 6 h, and DNA synthesis measured as described in Materials and Methods. Data are means 6 SD of three independent determina-
tions and are expressed as fold increase of the value determined after 1 d. Similar results were obtained in three additional experiments.
(B) Sphingosine kinase–transfected NIH 3T3 fibroblasts proliferate more rapidly than control cells. Cells stably transfected with c-myc–
pcDNA3 (j) or with c-myc–SPHK-pcDNA3 (h) were plated in 24-well tissue culture plates (1,000 per well), cultured for the indicated
days in the presence of 0.5% CS (B) or for 6 d in 10% CS (insert), stained with crystal violet, and quantitated as described in Materials
and Methods. Media was replaced every 2 d. Similar results were obtained in at least two additional experiments. (C) N,N-Dimethylsph-
ingosine, but not pertussis toxin, inhibits DNA synthesis induced by sphingosine kinase overexpression. Cells stably transfected with c-
myc–pcDNA3 (filled bars) or with c-myc–SPHK-pcDNA3 (open bars) were plated at 2 3 104 cells per well, washed after 24 h, and cul-
tured in serum-free DMEM containing 2 mg/ml transferrin and 20 mg/ml BSA, in the absence or presence of the indicated agents. After
16 h, cells were pulsed with 1.0 mCi of [3H]thymidine for 8 h, and incorporation of [3H]thymidine into trichloroacetic acid–insoluble
material was measured. Values are the means 6 SD of triplicate determinations, and similar results were found in three independent
experiments. Agents (concentration): pertussis toxin (PTX; 50 ng/ml); DMS (0.5 or 1 mM); PDGF (20 ng/ml); SPP (2 or 10 mM); dihy-
dro-SPP (DHSPP, 10 mM).The Journal of Cell Biology, Volume 147, 1999 552
ily of SPP receptors might be involved in the proliferative
response induced by overexpression of sphingosine kinase,
stably transfected 3T3 fibroblasts were treated with per-
tussis toxin, as these receptors are known to act through
pertussis toxin-sensitive G proteins (Lee et al., 1998; Van
Brocklyn et al., 1998; Kon et al., 1999; Sato et al., 1999). In
contrast to many other biological responses, including the
mitogenic effect of exogenous SPP, which are inhibited by
pertussis toxin (Goodemote et al., 1995), it did not abro-
gate the increase in DNA synthesis induced by expression
of sphingosine kinase in the presence of PDGF, suggesting
that sphingosine kinase acts independently of Gi proteins
(Fig. 4 C). In contrast, treatment of cells with a specific in-
hibitor of sphingosine kinase, N,N-dimethylsphingosine
(DMS), at a concentration that inhibits sphingosine kinase
and decreases SPP levels, blocked the effects of sphin-
gosine kinase overexpression (Fig. 4 C). Similar results
were obtained in cells transiently expressing sphingosine
kinase (data not shown). Moreover, although 2 mM SPP
stimulated proliferation in vector and sphingosine kinase–
transfected cells (Fig. 4 C, inset), 10 mM SPP markedly
stimulated DNA synthesis of vector-transfected cells while
inhibiting proliferation of sphingosine kinase–transfected
cells. Interestingly, 10 mM dihydro-SPP, which lacks the
trans double bond present in SPP and binds and signals
through Edg-1, -3, and -5 (Van Brocklyn et al., 1998,
1999), only slightly stimulated DNA synthesis in both vec-
tor- and kinase-transfected cells (Fig. 4 D, inset), suggest-
Figure 5. Expression of sphingosine kinase in NIH 3T3 fibroblasts reduces apoptosis induced by serum deprivation. (A) NIH 3T3 fibro-
blasts were transiently transfected with vector (j) or SPHK1a (h), together with pCEFL-GFP, and serum starved for the indicated
times. Total GFP-expressing cells and GFP-expressing cells displaying fragmented nuclei indicative of apoptosis were counted as de-
scribed in Materials and Methods. A minimum of 500 cells in each field were scored. Data are mean 6 SEM of three independent exper-
iments, each one done in duplicate or triplicate. (B) Stably vector-transfected (filled bars) or c-myc–tagged SPHK1a (open bars)-trans-
fected NIH 3T3 cells were serum starved in the absence (None) or presence of 50 nM staurosporine (Staur) or 10% serum plus 250 nM
staurosporine (CS1Staur) for 24 h. Percentages of apoptotic cells were determined after Hoechst staining by fluorescence microscopy.
(C) Note the typical condensed fragmented nuclei of apoptotic cells in vector but not in SPHK-overexpressing cells after serum depriva-
tion. (D) DMS, but not pertussis toxin, inhibits the protective effect of sphingosine kinase. Stably vector- or c-myc–tagged SPHK1a-
transfected NIH 3T3 cells were serum starved in the absence (None) or presence of 5 mM DMS, 20 ng/ml pertussis toxin (PTX), 25 mM
C2-ceramide (C2-Cer) or both for 24 h, and the number of viable cells was determined as described in Materials and Methods. Percent
protection from apoptosis by sphingosine kinase expression 5 1003 [(percent viable sphingosine kinase cells 2 percent of viable vector
cells)/(percent of viable vector-transfected cells)].
Table III. Flow Cytometric Analysis of Cell 
Cell cycle distribution
Cells G0/G1 SG 2/M
Percentage of cells
Vector, 0.5% CS 96.4 6 0.8 1.6 6 0.4 1.9 6 0.4
SPHK, 0.5% CS 90.4 6 0.7* 6.4 6 0.1* 3.2 6 0.4*
Vector, 10% CS 65.4 6 0.1* 25.4 6 0.2* 9.5 6 0.2*
SPHK, 10% CS 57.5 6 0.7* 32.1 6 0.6* 10.4 6 0.1‡
NIH 3T3 cells stably transfected with c-myc–pcDNA3 (Vector) or c-myc–pcDNA3-
SPHK1a (SPHK) were plated at 500,000 cells/150-mm dish. After 24 h, cells were
washed twice with DMEM and incubated in media containing 0.5 or 10% CS for 2 d.
Cell-cycle analysis was then performed by flow cytometry as described in Materials
and Methods.
*Significant differences from vector-transfected values as determined by Student’s t
test (P # 0.01).
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ing that SPP receptors are equally responsive in vector as
well as sphingosine kinase–transfected cells.
Effect of Sphingosine Kinase Overexpression on 
Programmed Cell Death
Exogenous SPP has been shown to suppress apoptosis in-
duced by cytokines, such as TNF and Fas ligand (Cuvillier
et al., 1996), serum deprivation (Edsall et al., 1997; Van
Brocklyn et al., 1998), and to be important in the survival
effects of NGF (Edsall et al., 1997), vitamin D3 (Kleuser
et al., 1998), and cAMP (Machwate et al., 1998). In con-
trast, more recently it has been suggested that SPP pro-
tected human T lymphoblastoma cells from apoptosis
induced by antibodies to Fas, CD2, and CD3/CD28, or C6-
ceramide by binding to EDG-3 and EDG-5 GPCRs
(Goetzl et al., 1999). However, if the intracellular level of
SPP is a critical factor that determines cell survival, then it
is expected that overexpression of sphingosine kinase
should suppress apoptosis. In agreement with previous
studies (Brancolini et al., 1997), prolonged serum depriva-
tion induced apoptosis in NIH 3T3 fibroblasts (Fig. 5 A),
where shrinkage and condensation of nuclei were clearly
evident (Fig. 5 C). Transient and stable expression of sphin-
gosine kinase in NIH 3T3 fibroblasts suppressed the ap-
pearance of apoptotic nuclei induced by serum starvation
(Fig. 5, A–C). In contrast, sphingosine kinase expression
had almost no effect on apoptosis resulting from treatment
with staurosporine (Fig. 5 B), a broad spectrum protein ki-
nase inhibitor that is known to induce apoptosis in normal
and neoplastic cells (Jacobsen et al., 1996). Moreover,
DMS, but not pertussis toxin, inhibited the cytoprotective
effect of sphingosine kinase overexpression in stably (Fig.
5 D) as well as transiently transfected NIH 3T3 fibroblasts.
It should be pointed out that serum withdrawal mark-
edly increases ceramide levels in many cell types, and it
has been proposed that ceramide mediates, at least in part,
serum deprivation–induced cell death (Hannun, 1996).
Thus, it was of interest to examine the effect of sphin-
gosine kinase expression on apoptosis of other types of
cells. Expression of sphingosine kinase in HEK293 cells
also markedly inhibited apoptosis induced by serum depri-
vation and by the cell permeable ceramide analogue, C2-
ceramide, although to a lesser extent (Fig. 6 A). These cy-
toprotective effects of sphingosine kinase overexpression
were also not inhibited by pertussis toxin treatment. In
contrast, apoptosis induced by staurosporine, a well recog-
nized inducer of apoptosis in HEK293 cells (Ozawa et al.,
1999), was not suppressed by expression of sphingosine ki-
nase (Fig. 6 A).
Caspases, a family of aspartate-specific cysteine pro-
teases, play a critical role in the execution phase of apop-
totic cell death by cleavage of a specific set of cytosolic and
nuclear proteins leading to disassembly of the cell (Nichol-
son et al., 1995; Thornberry and Lazebnik, 1998). Fig. 6 B
demonstrates that serum withdrawal induced activation of
caspase-3, as shown by the appearance of the p20 and p17
subunits, which correlated with the onset of apoptosis.
Overexpression of sphingosine kinase reduced processing
of caspase-3 (Fig. 6 B).
Human leukemic Jurkat T cells are a well-characterized
model system that readily undergo apoptosis and are sen-
sitive to C2-ceramide–induced apoptosis (Cuvillier et al.,
1998). Moreover, exogenous SPP suppressed Fas- and cer-
amide-mediated apoptosis in these cells (Cuvillier et al.,
1998). Serum deprivation or brief treatment of Jurkat T
cells (3 h) with Fas monoclonal antibody or C2-ceramide
caused extensive cell death, as measured by the appear-
ance of nuclear fragmentation, which was reduced by ex-
Figure 6. Sphingosine kinase inhibits serum-deprivation– and
C2-ceramide–induced apoptosis, but not staurosporine-induced
apoptosis, in HEK293 cells. (A) HEK293 cells stably expressing
empty vector (filled bars) or c-myc–tagged SPHK1a (open bars)
were incubated in serum-free medium for 30 h, and then treated
in the absence (None) or presence of 25 mM C2-ceramide (C2-
Cer) or 100 nM staurosporine (Staur) for 24 h. Percentages of
apoptotic cells were determined after Hoechst staining by fluo-
rescence microscopy. Data are means 6 SEM of four indepen-
dent experiments, each done in triplicate. *Significant differences
from vector-transfected values (P # 0.05). (B) Expression of
sphingosine kinase inhibits activation of caspase-3. HEK293 cells
expressing empty vector (Vect) or c-myc–tagged SPHK1a
(SPHK) were incubated in serum-free medium and cytosolic ex-
tracts were prepared at the indicated times. Proteins were re-
solved by 15% SDS-PAGE, blotted, and probed with anti–
caspase-3. Migrations indicated are: full-length caspase-3, the
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pression of sphingosine kinase (data not shown). The fluo-
rogenic substrate Ac-DEVD-AMC, which corresponds to
the cleavage site found in executioner caspases targets,
was used to measure the activation of these caspases. In-
deed, serum deprivation, Fas ligation, and C2-ceramide
treatment of Jurkat cells resulted in a time-dependent in-
crease in DEVDase proteolytic activity (Fig. 7 A), which
preceded the appearance of fragmented nuclei. Overex-
pression of sphingosine kinase blocked the increase in
DEVDase activity induced by serum deprivation and C2-
ceramide (Fig. 7 A) and had a lesser yet still significant
effect on Fas ligation–induced DEVDase activation. In
agreement, sphingosine kinase effectively prevented acti-
vation of caspase-3, as measured by the decrease of its pro-
cessing to p20 and p17 forms following serum deprivation
and C2-ceramide addition, but had a smaller effect on Fas-
induced activation (Fig. 7 B).
Discussion
Apparently contradictory reports describe intra- and ex-
tracellular actions of SPP in diverse cell types (Goetzl and
An, 1998; Spiegel, 1999). While much evidence has accu-
mulated recently indicating that SPP functions as a ligand
for the EDG family of GPCRs, which are linked to diverse
biological responses (Goetzl and An, 1998; Spiegel, 1999),
less is known of the role of SPP as a second messenger.
SPP has been proposed as an intracellular mediator of cell
growth (Spiegel et al., 1996), mainly based on the use of
exogenously added SPP in the high micromolar range,
stimulation of sphingosine kinase by growth factors, as
well as sphingosine kinase inhibitors. For example, in
Swiss 3T3 cells, competitive inhibitors of sphingosine ki-
nase block some of the proliferative signals elicited by
PDGF (Olivera and Spiegel, 1993), including activation of
mitogen-activated protein kinase, cyclin-dependent ki-
nases (Cdc2 and Cdk2 kinases), and activation of the tran-
scription factor AP1 (Rani et al., 1997; Su et al., 1994).
However, the proliferative response to exogenously added
SPP is partially sensitive to pertussis toxin, suggesting the
potential involvement of Gi-coupled cell surface receptors
(Goodemote et al., 1995). Thus, it was important to de-
velop another approach to unequivocally determine the
role of intracellularly generated SPP. To this end, we tran-
siently and stably transfected cells with sphingosine ki-
nase, which markedly increased intracellular levels of SPP.
In contrast to activated platelets that release stored SPP in
a PKC-dependent manner (Yatomi et al., 1997b), trans-
fected NIH 3T3 fibroblasts and HEK293 cells did not se-
crete any detectable SPP, suggesting that only certain cell
types are capable of secreting SPP and that these trans-
fected cells should be useful to study the intracellular roles
of SPP. Interestingly, SPP levels were increased to the
same extent by sphingosine kinase expression in both the
cytosol and in membrane fractions, whereas other sphin-
golipid metabolites, ceramide and sphingosine, are pre-
dominantly located in membranes. This observation is
very intriguing since it might suggest that, similar to an-
other second messenger, inositol trisphosphate, it can
move between intracellular compartments.
BrdU incorporation, cell cycle analysis, and growth
curves indicate that sphingosine kinase transfection can
significantly increase the proliferative rate of nontrans-
formed NIH 3T3 fibroblasts. Enforced expression of
sphingosine kinase not only resulted in higher levels of SPP,
it also increased the proportion of cells in the S phase of the
cell cycle, expedited the G1/S transition, and reduced the
doubling time, especially in low serum conditions, indicat-
ing that intracellular SPP is an important regulator of cell
growth. In support of this notion, microinjection of SPP
(Van Brocklyn et al., 1998) or intracellular generation of
SPP by photolysis of incorporated caged SPP (Qiao et al.,
Figure 7. Expression of sphingosine kinase suppresses DEVDase
activity and inhibits caspase-3 activation induced by serum star-
vation, C2-ceramide and Fas ligation in Jurkat T cells. (A) Jurkat
T cells transfected with vector (filled bars) or SPHK1a (open
bars) were serum starved for 3 or 24 h or incubated for 3 h in se-
rum-free media in the presence of 10 or 20 mM C2-ceramide (C2-
Cer) or agonistic Fas antibody (50 ng/ml). Activation of DEVD-
specific caspases was measured by the cleavage of the fluorogenic
substrate Ac-DEVD-AMC. All values for sphingosine kinase–
transfected cells were significantly different from vector-trans-
fected cells as determined by Student’s t test (P # 0.01). (B) Cel-
lular extracts from Jurkat cells stably transfected with empty
vector (Vect) or SPHK1a expression vector (SPHK) were treated
for 3 h without (Control) or with the indicated concentration of
C2-ceramide or anti–Fas as described in A, separated by SDS-
PAGE and immunoblotted with anti–caspase-3. The migration
positions of full-length 32-kD caspase-3 and proteolytically pro-
cessed intermediate p20 and active subunit p17 are indicated.Olivera et al. Sphingosine Kinase Cell Growth and Survival 555
1998), stimulated DNA synthesis of Swiss 3T3 fibroblasts.
Moreover, in contrast to the sphingosine kinase inhibitor,
pertussis toxin did not suppress proliferation induced by
sphingosine kinase overexpression. However, pertussis
toxin markedly inhibited SPP-induced proliferation of en-
dothelial cells (Wang et al., 1999b). It is possible that
there is a complex interplay between cell surface receptor
signaling and intracellular targets for SPP, which can con-
tribute to its mitogenic response in certain cell types.
Moreover, the discovery of G protein–coupled receptors
in the nucleus (Bhattacharya et al., 1998) and the pres-
ence of intracellular EDG-1 in distinct perinuclear loca-
tion (Liu et al., 1999) raises the possibility that intracellu-
lar SPP might signal through receptors located inside
cells.
Sequence analyses identified homologues of sphingo-
sine kinase in numerous widely disparate organisms, in-
cluding yeast (Kohama et al., 1998; Nagiec et al., 1998),
demonstrating that sphingosine kinase is a member of a
novel but highly conserved gene family and is distinct from
almost all other known lipid kinases. Interestingly, of all
the lipid kinases, sphingosine kinase shares the highest de-
gree of homology to diacylglycerol kinase z (DGK-z) (Ko-
hama et al., 1998). However, overexpression of DGK-z,
which regulated diacylglycerol levels in the nucleus (Top-
ham et al., 1998), had opposite effects to sphingosine ki-
nase on the cell cycle, increasing the doubling time and the
fraction of cells in the G1/G0 phase of the cell cycle (Top-
ham et al., 1998).
The effects of SPP on cell growth appear to be evolu-
tionarily conserved, as phosphorylated long-chain sphin-
goid bases also regulate proliferation and survival of yeast
(Lanterman and Saba, 1998; Mandala et al., 1998; Gottlieb
et al., 1999; Skrzypek et al., 1999). Spontaneous mutants of
Saccharomyces cerevisiae with diminished sphingosine ki-
nase activity had reduced growth rates and failed to pass
through the diauxic shift and successfully initiate respira-
tory growth (Lanterman and Saba, 1998), suggesting that
yeast sphingosine kinase might play a role in mediating
growth responses to changes in nutrients. Because exoge-
nously added dihydro-SPP was unable to affect yeast
growth (Lanterman and Saba, 1998), these results further
substantiate a role for intracellular SPP in cell growth reg-
ulation. In agreement, deletion of SPP lyase, which results
in accumulation of phosphorylated sphingoid bases in
yeast, causes unregulated proliferation on approach to the
stationary phase (Gottlieb et al., 1999). Moreover, expres-
sion of G1 cyclin, whose downregulation may be directly
involved in mediating the growth arrest induced by starva-
tion, was maintained at a higher level throughout the post-
diauxic phase in these lyase-deficient yeast (Gottlieb et al.,
1999). This growth advantage was associated with a failure
to arrest cells in G1 and a marked increase in stationary
phase DNA content per cell. In agreement, overexpres-
sion of LBP1 and LBP2, which are specific SPP phos-
phatases (Mandala et al., 1998), reduced levels of long-
chain phosphorylated sphingoid bases and arrested cells
prematurely at the G1 phase of the cell cycle (Mao et al.,
1999). These effects on the yeast cell cycle are mirror im-
ages of the effects of overexpression of sphingosine kinase
and increased SPP levels in mammalian cells that result in
shortening of the G1 phase of the cell cycle and accumula-
tion of cells in the S phase when deprived of growth fac-
tors.
Sphingosine kinase activity and SPP levels can be regu-
lated by growth and survival factors (Spiegel and Merrill,
1996; Spiegel et al., 1998). Interestingly, the levels of SPP
in 3T3 fibroblasts overexpressing sphingosine kinase, de-
spite the enormous increases in in vitro activity, were max-
imally increased only four- to eightfold. This level was sim-
ilar to the level of SPP produced in the same cells after
stimulation by PDGF and serum, addition of sphingosine,
or even SPP itself (Olivera and Spiegel, 1993). These ob-
servations suggest that cells tightly regulate their levels of
SPP, consistent with its role as a second messenger. In ad-
dition to sphingosine kinase, rapid degradation by SPP
lyase and/or SPP phosphatase may also play an important
role in determining the steady state levels of SPP. Another
possible explanation for the lack of correlation of sphin-
gosine kinase activity and SPP levels is that the substrate
for the overexpressed sphingosine kinase, sphingosine,
may be located in a different subcellular compartment.
Exogenous SPP (2 mM) stimulated growth of vector-trans-
fected and sphingosine kinase overexpressing cells; how-
ever, high concentrations of SPP (10 mM) inhibit, rather
than enhance, growth of sphingosine kinase–transfected
cells. In agreement, while increases in intracellular levels
of long-chain phosphorylated sphingoid bases enhance
growth of yeast (Lanterman and Saba, 1998; Gottlieb et al.,
1999), substantially higher increases reduce their growth
rate (Skrzypek et al., 1999).
Paradoxically, although the processes of cell growth and
cell death appear to be opposing and mutually contradic-
tory, substantial evidence now suggests that the pathways
of apoptosis and mitosis may be mechanistically related or
tightly coupled (Harrington et al., 1994; Evan and Little-
wood, 1998). Mammalian cells overexpressing sphingosine
kinase not only had higher growth rates, but also exhibited
enhanced survival in serum-free conditions. Previously, it
was shown that exogenous SPP can antagonize apoptosis
mediated by a number of stress stimuli, including serum
withdrawal, TNF-a, Fas ligation, and ceramide elevation
(Cuvillier et al., 1996; Edsall et al., 1997). However, the
importance of intracellular SPP has been challenged by
the recent suggestion that protection from apoptosis may
be mediated by binding of SPP to EDG-3 and EDG-5
GPCRs (Goetzl et al., 1999). In contrast, our results indi-
cate that increased cellular SPP levels in various cell types
due to overexpression of sphingosine kinase mimics the
protective effect of exogenous SPP against apoptosis, es-
pecially in response to growth factor withdrawal, support-
ing the concept that the cytoprotective actions of SPP are
mediated intracellularly. In agreement, we previously
found that dihydroSPP, which binds to and signals through
the EDG family of GPCRs (Van Brocklyn et al., 1998, 1999),
unlike SPP, did not prevent apoptosis and conversely, the
nonhydrolyzable SPP-phosphonate, which does not bind
to these receptors, mimicked the effect of SPP on prolifer-
ation and survival (Van Brocklyn et al., 1998). Because the
sphingolipid metabolite ceramide is a mediator of stress
responses (Hannun, 1996; Kolesnick and Kronke, 1998),
both in mammalian cells and in yeast (Dickson et al., 1997;
Jenkins et al., 1997; Nickels and Broach, 1996), we pro-
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sphingolipid metabolites (ceramide and SPP) is an impor-
tant factor that determines whether cells will survive or die
(Cuvillier et al., 1996; Mandala et al., 1998). Consistent
with this hypothesis, we found that transient expression of
sphingosine kinase modified the sphingolipid metabolite
balance, resulting in higher levels of SPP, with concomi-
tant decreases in the levels of sphingosine and ceramide
(Kohama et al., 1998). Our present results show that ex-
pression of sphingosine kinase in 3T3 fibroblasts, HEK
293, and Jurkat T cells suppressed apoptosis induced by
serum deprivation, known to increase ceramide levels, or
by the ceramide analogue, C2-ceramide, with concomitant
inhibition of activation of the executionary caspase-3. Sim-
ilarly, transient expression of sphingosine kinase in U937
cells reduced apoptosis induced by both serum starvation
and TNF-a treatment, as determined by DNA fragmenta-
tion and DEVDase activity assays (Cuvillier, O., and S.
Spiegel, unpublished observations), suggesting that the
protective effects of intracellularly generated SPP are not
restricted to certain cell types. Because the proximal mo-
lecular targets by which ceramide activates caspase-3 and
related CED-3 subfamily caspases remain largely uniden-
tified, further work is necessary before the target(s) for
SPP can be more precisely identified.
This survival function of SPP might also be part of an
ancient stress response since, in S. cerevisiae, nutrient dep-
rivation activates sphingosine kinase and yeast mutants,
with decreased sphingosine kinase activity also displayed
an increased sensitivity to heat stress (Lanterman and
Saba, 1998). Furthermore, accumulation of phosphory-
lated long chain sphingoid bases in S. cerevisiae either due
to the deletion of LBP1 and LBP2 genes (Mandala et al.,
1998), or deletion of DPL1, a gene encoding long-chain–
base phosphate lyase (Saba et al., 1997), correlates with in-
creased survival at an elevated temperature (Lanterman
and Saba, 1998; Mao et al., 1999; Skrzypek et al., 1999),
suggesting that long-chain–base phosphates may play a
physiological role in heat stress resistance in yeast.
In summary, this study substantiates a role for sphin-
gosine kinase–derived SPP as a second messenger in cell
proliferation and survival. Sphingosine kinase belongs to a
new class of lipid kinases, different in structure and bio-
chemical properties than other lipid kinases, such as the
phosphatidylinositol 3-kinase family, but similar in the
broad spectrum of signals and in vital and versatile cell
functions that they regulate.
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